Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11551
KULR Technology Group
KULR
$123M
| $22.5K | ﹤0.01% |
+9,888
| New | +$22.2K |
|
|
MAPS
11552
DELISTED
WM TECHNOLOGY INC A
MAPS
| $22.5K | ﹤0.01% |
25,881
+15,841
| +158% | +$15.8K |
|
|
ICAD
11553
PUT
DELISTED
iCAD Inc
ICAD
| $22.5K | ﹤0.01% |
14,300
-5,500
| -28% | -$7.89K |
|
11554
Bionano Genomics
BNGO
$14.3M
| $22.3K | ﹤0.01% |
820
+13
| +2% | +$404 |
|
11555
SurgePays
SURG
$4.42M
| $22.3K | ﹤0.01% |
+12,093
| New | +$27.4K |
|
11556
Asia Pacific Wire & Cable
APWC
$58.1M
| $22.2K | ﹤0.01% |
14,343
+2,673
| +23% | +$3.99K |
|
11557
BioRestorative Therapies
BRTX
$5.25M
| $22.2K | ﹤0.01% |
+12,774
| New | +$21K |
|
|
KYNB
11558
Kyntra Bio
KYNB
$32.4M
| $22.1K | ﹤0.01% |
2,214
-17,110
| -89% | -$258K |
|
|
KLRS
11559
Kalaris Therapeutics
KLRS
$97.6M
| $22K | ﹤0.01% |
1,183
-6,126
| -84% | -$107K |
|
|
CAPT
11560
DELISTED
Captivision
CAPT
| $21.9K | ﹤0.01% |
+11,075
| New | +$24.1K |
|
|
11561
PUT
KULR Technology Group
KULR
$123M
| $21.9K | ﹤0.01% |
9,450
+7,712
| +444% | +$17.3K |
|
|
LICY
11562
PUT
DELISTED
Li-Cycle Holdings Corp.
LICY
| $21.9K | ﹤0.01% |
10,000
-7,000
| -41% | -$19.3K |
|
|
VTYX
11563
CALL
DELISTED
Ventyx Biosciences
VTYX
| $21.8K | ﹤0.01% |
10,000
-181,700
| -95% | -$418K |
|
11564
Lulu's Fashion Lounge
LVLU
$37.8M
| $21.8K | ﹤0.01% |
+908
| New | +$20.3K |
|
|
ARBK
11565
CALL
Argo Blockchain
ARBK
$43.6M
| $21.8K | ﹤0.01% |
83
-15
| -15% | -$4.12K |
|
11566
PUT
Taysha Gene Therapies
TSHA
$1.94B
| $21.5K | ﹤0.01% |
10,700
-11,700
| -52% | -$25.7K |
|
11567
PUT
Nerdy
NRDY
$88M
| $21.5K | ﹤0.01% |
1,460
+53
| +4% | +$1.02K |
|
11568
BioXcel Therapeutics
BTAI
$22.5M
| $20.9K | ﹤0.01% |
2,138
-8,694
| -80% | -$117K |
|
|
GENE
11569
DELISTED
Genetic Technologies Ltd.
GENE
| $20.7K | ﹤0.01% |
27,617
-49,686
| -64% | -$44.2K |
|
|
RAPT
11570
DELISTED
RAPT Therapeutics
RAPT
| $20.5K | ﹤0.01% |
1,275
-117
| -8% | -$2.37K |
|
11571
Dominari Holdings
DOMH
$60.4M
| $20.4K | ﹤0.01% |
11,051
-5,484
| -33% | -$9.75K |
|
|
11572
CALL
SurgePays
SURG
$4.42M
| $20.2K | ﹤0.01% |
11,000
-141,500
| -93% | -$321K |
|
|
ASRT
11573
PUT
DELISTED
Assertio
ASRT
| $20.2K | ﹤0.01% |
1,140
-307
| -21% | -$6.09K |
|
|
NAK
11574
Northern Dynasty Minerals
NAK
$984M
| $20.1K | ﹤0.01% |
60,676
-118,556
| -66% | -$41.6K |
|
11575
Tenaya Therapeutics
TNYA
$156M
| $20K | ﹤0.01% |
10,339
-32,679
| -76% | -$92.3K |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.